Paloma Cejas, PhD

I graduated from the Autonomous University of Madrid and continued my training at Hospital La Paz in Madrid where I established a program of translational cancer research focused on biomarkers identification.  At Dana-Farber Cancer Institute, I acquired extensive experience in cancer epigenetics and have contributed to cancer subclassification and to the characterization of intratumor heterogeneity based on chromatin analysis. I also have vast experience developing methodologies including methods for single-cell interrogation of tissues and for chromatin profiling of FFPE clinical samples. My goal is to apply my knowledge and high-resolution methodologies to rigorously investigate well-annotated clinical cohorts to advance in the understanding of cancer progression and treatment resistance. I am a very collaborative researcher always interested in partnering with research groups in academia and industry to translate biology to clinical applications.